GGrantIndex
← Leaderboards

Kate Basia Wolitzky-Taylor

University Of California Los Angeles

$2,134,402
Attributed
$2,314,472
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY201225
$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,478,010 · 5

By mechanism

P50$10,163,538 · 1
R34$1,191,627 · 2
K23$762,704 · 1
R21$360,141 · 1

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Cognitive Therapy

Research focus

Cognitive TherapyAnxietyEvidence BaseTrainingSymptomsResourcesPublic HealthTreatment OutcomeBehavioralEffectivenessComorbidityCommunitiesCognitiveAffectProgramsMental HealthDesignLos AngelesFundingSubstance Use DisorderPersonsCaringMediatingMental Depression

Grant awards (20)

Screening, Tracking and Treatment for Anxiety and Depression in Community Colleges$2,712,362
P50 · FY2025 · MH
Screening, Tracking and Treatment for Anxiety and Depression in Community Colleges$2,337,984
P50 · FY2024 · MH
Screening, Tracking and Treatment for Anxiety and Depression in Community Colleges$375,938
P50 · FY2024 · MH
Screening, Tracking and Treatment for Anxiety and Depression in Community Colleges$2,351,894
P50 · FY2023 · MH
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids$162,342
R21 · FY2023 · DA · contact PI
Screening, Tracking and Treatment for Anxiety and Depression in Community Colleges$2,385,360
P50 · FY2022 · MH
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids$197,799
R21 · FY2022 · DA · contact PI
Developing and Evaluating a Fully Integrated Treatment Program for Comorbid Social Anxiety and Alcohol Use Disorders$102,468
R34 · FY2020 · AA · contact PI
Developing and Evaluating a Fully Integrated Treatment Program for Comorbid Social Anxiety and Alcohol Use Disorders$150,580
R34 · FY2019 · AA · contact PI
Targeting maladaptive responding to negative affect in adolescent cannabis users$149,662
R34 · FY2019 · DA · contact PI
Developing and Evaluating a Fully Integrated Treatment Program for Comorbid Social Anxiety and Alcohol Use Disorders$248,010
R34 · FY2018 · AA · contact PI
Targeting maladaptive responding to negative affect in adolescent cannabis users$239,535
R34 · FY2018 · DA · contact PI
Developing and Evaluating a Fully Integrated Treatment Program for Comorbid Social Anxiety and Alcohol Use Disorders$152,709
R34 · FY2017 · AA · contact PI
Targeting maladaptive responding to negative affect in adolescent cannabis users$148,663
R34 · FY2017 · DA · contact PI
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders$150,811
K23 · FY2016 · DA · contact PI
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders$150,811
K23 · FY2015 · DA · contact PI
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders$150,811
K23 · FY2014 · DA · contact PI
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders$150,811
K23 · FY2013 · DA · contact PI
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders$130,324
K23 · FY2012 · DA · contact PI
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders$29,136
K23 · FY2012 · DA · contact PI